These results suggest that the BAF complex contributes to the establishment of latent infections and points to the ATP-dependent enzyme BRG1 as a putative therapeutic target to deplete the latent HIV-infected reservoir in infected patients. The gene discussed is BANF1; the disease is disease arising from reactivation of latent virus.